Playback speed
10 seconds
SGO 2024 Insights: "The Use of Rucaparib vs. Placebo Maintenance Therapy in Metastatic & Recurrent Endometrial Cancer"
By
Insights from 2024 SGO Annual Meeting
FEATURING
Bradley Corr
By
Insights from 2024 SGO Annual Meeting
FEATURING
Bradley Corr
181 views
March 29, 2024
Login to view comments.
Click here to Login